Skip to content

← All stories

Markets

Summit Therapeutics (SMMT) Soars 28% on Ivonescimab Progress

1 source ·1 article ·4h ago

Covered by 1 outlet

All coverage · 1 article

Yahoo Finance News ·4h ago

Summit Therapeutics (SMMT) Soars 28% on Ivonescimab Progress